A new study on mice suggests that a copper compound could be used in therapy for Lou Gehrig’s disease – also known as amyotrophic lateral sclerosis – an incurable, fatal disease, reports [s]Medical News Today[/s]. The researchers, from Australia, the US and the UK, demonstrated in mice that oral administration of this compound extended lifespan and improved locomotor function of transgenic mice genetically engineered to develop amyotrophic lateral sclerosis (ALS). The researchers say that, no therapy for ALS has ever been able to extend lifespan for more than a few extra months in humans. However, they note that their newly discovered approach could change this, potentially helping with Parkinson’s disease as well.
[link url=http://www.medicalnewstoday.com/articles/278266.php]Full Medical News Today report[/link]
[link url=http://www.jneurosci.org/content/34/23/8021.abstract?sid=1bb3c44f-ee02-46e4-896f-6050c6e7c4dd]Journal of Neuroscience abstract[/link]